Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Protagonist Therapeutics Inc (PTGX)

15.94 -0.42 (-2.57%)

10/16/2017  4:00pm

Open:

15.73

Pre. Close:

16.36

High:

16.48

Low:

15.68

Volume:

167,424

Market Cap:

269.42M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

-

-

Low:

-

-

Close:

-

-

Technical analysis  (as of: 2017-10-16 4:47:38 PM)

Overall:

      

Stoxline posted a SELL today, upgraded from strong sell. But this stock still is very strong for short side. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell as long as the BUY warning is not issued.

Target:

Six months: 20.71     One year: 23.30

Support:

Support1: 14.13    Support2: 11.76

Resistance:

Resistance1: 17.73    Resistance2: 19.95

Pivot:

17.96

Moving Averages:

MA(5): 17.71     MA(20): 17.69

MA(100): 13.59     MA(250): 15.56

MACD:

MACD(12,26): 0.54     Signal(12,26,9): 0.90

%K %D:

%K(14,3): 13.79     %D(3): 42.74

RSI:

RSI(14): 42.85

52-Week:

High: 26.36  Low: 8.00  Change(%): -28.9

Average Vol(K):

3-Month: 8068  10-Days 17062

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
PTGX has closed above bottom band by 7.5%. Bollinger Bands are 34.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 11 Oct 2017 19:52:30 GMT
Protagonist Therapeutics Announces Proposed Public Offering of Common Stock

Wed, 20 Sep 2017 12:00:00 GMT
Protagonist Therapeutics Announces Preliminary Phase 1 Study Results with ...

Tue, 17 Oct 2017 00:33:37 GMT
$-0.95 EPS Expected for Protagonist Therapeutics Inc (PTGX)

Fri, 13 Oct 2017 17:48:45 GMT
The Case for and Against Protagonist Therapeutics, Inc. (PTGX)

Thu, 08 Jun 2017 12:00:00 GMT
Protagonist Therapeutics Appoints Five Prime Therapeutics CEO, Lewis T. "Rusty ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

Shares Float (M)

6.66

% Held by Insiders

6.84

% Held by Institutions

88.74

Shares Short (K)

719

Shares Short Prior Month (K)

728

Stock Financials

EPS

-3.230

EPS Est. Current Year

EPS Est. Next Year

-2.260

EPS Est. Next Quarter

-0.720

Forward EPS

1.#IO

Book Value (p.s.)

3.610

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-63.1

Return on Equity (ttm)

-116.4

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-2.817

Qtrly Earnings Growth

Operating Cash Flow (M)

-39.34

Levered Free Cash Flow (M)

-23.47

FoxReading.com

Valuation

P/E

-4.93

P/E Growth Ratio

-0.03

P/BV

4.42

P/S

P/CF

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.